In summary, we demonstrated that SETD2 alterations were associated with worse PFS in Chinese patients with MDS, in addition, SETD2 loss may modulate genomic stability and upregulate DVL3 expression through Wnt/β-catenin signaling. This evidence concerns the gene SETD2 and myelodysplastic syndrome.